Back to Selection     Print       Date : 31 Mar 2025
Fund Summary
Tata India Pharma & HealthCare Fund Reg Plan (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 28-Dec-2015
Corpus(Cr.) 1184.0 Latest NAV 29.2419 As on 30-05-2025
Equity(%) 95.78 52 Week High 32.0131
Debt(%) 4.22 52 Week Low 24.616
Others(%) 0.0 Exit Load 0.25% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.17
Scheme Benchmark NIFTY Pharma TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Meeta Shetty
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks long term capital appreciation by investing atleast 80% of it`s net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 35.89%
Top 10 Holdings 57.48%
Top 25 Holdings 88.17%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 65.0
Healthcare 26.57
Cash 4.22
Miscellaneous 1.61
Fertilisers 1.0
Retail 0.76
Software & Services 0.54
Chemicals 0.3
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.14
PE Ratio 28.07
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 11.79
Aurobindo Pharma Limited 7.27
Cipla Limited 5.97
Apollo Hospitals Enterprise Limited 5.66
Lupin Limited 5.20
DIVI LABORATORIES LTD 5.12
Fortis Health Care Ltd 5.05
CASH / NET CURRENT ASSET 4.01
Aster DM Healthcare Limited 3.91
Dr Reddys Laboratories Limited 3.50
Wockhardt Limited 3.31
Alkem Laboratories Limited 3.10
Healthcare Global Enterprises Limited 3.05
Laurus Labs Limited 2.62
Ajanta Pharma Limited 2.10
Torrent Pharmaceuticals Limited 1.93
IPCA Laboratories Limited 1.81
Metropolis Healthcare Limited 1.80
Krishna Inst of Medical Sciences Ltd. 1.77
Dr Agarwals Health Care Limited 1.71
Medi Assist Healthcare Services Limited 1.61
FDC Limited 1.57
Dr Lal Path Labs Ltd 1.47
EQ- JUPITER LIFE LINE HOSPITALS LTD 1.44
Zydus Lifesciences Limited 1.40

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-0.37% 10.04% -4.07% 16.86%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.92% 12.13% 3.05% 11.08%
 
Scheme Benchmark [NSE - Nifty Pharma]
-1.52% 8.22% -3.59% 14.08%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
31.40% 22.62% 21.31% 0.00%
 
 
16.89% 15.56% 22.29% 12.73%
 
 
30.05% 19.38% 17.01% 5.53%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Tata India Pharma & HealthCare Fund Reg Plan (G) 16.83% 0.0000 0.0000% 0.0000 0.0000
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Tata India Pharma & HealthCare Fund Reg Plan (G) 0.0000% 0.0000 0.0000 0.0000 0.0000
 
Back to Selection